TOPLINE: Nearly half of patients with chronic hepatitis D virus (HDV) infection treated with bulevirtide achieved the combined primary endpoint ...
Statins have disease-modifying potential in people with non-cirrhotic chronic liver disease (CLD) by reducing the risk for progression to severe ...
WASHINGTON (AP) — Too many Americans are missing out on a cure for hepatitis C, and a study underway in ...
WASHINGTON — Adding granulocyte-colony stimulating factor (G-CSF) to steroid therapy can improve 90-day survival for patients with severe alcoholic hepatitis ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.